AzTrials
AzTrials

Postoperative PainTAPNCT02029755

Transversus Abdominis Plane Block Versus Local Anesthetic Infiltration for Pain Control in the Abdominal Surgery

A study testing transversus abdominis plane block and local infiltration in people with Postoperative Pain, run by Taipei Medical University Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Postoperative analgesia is an important part of the anesthetic care. According to the recent studies, multimodal analgesia can provide better analgesia \& patient satisfaction with fewer side effect. Read more about this study

Who is it for?
Ages 20 to 65 years
Conditions the study is for
Postoperative Pain
What is being tested?
transversus abdominis plane block and local infiltration
Could I receive a placebo?
No, everyone receives an active treatment
How many people
108 participants
Where
1 siteTaiwan
Study dates
Dec 2013to Jun 2014
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult (20~65y/o)
  • American Society of Anesthesiologists (ASA) physical status I~II
  • Patients scheduled for regular abdominal surgery under general anesthesia

Who cannot join

  • ASA physical status ≥ 3
  • Allergy to morphine or local anesthetics
  • Morphine tolerance
  • Drug abuse or addiction
  • Bleeding tendency

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Taipei Medical University Hospital

    Taipei, Taiwan, 110

Other trials in Taiwan

About this study

Official title: Ultrasound-guided-transversus Abdominis Plane(TAP) Block Versus Local Anesthetic(LA) Infiltration-the Effectiveness of Post-operative Pain Control in the Abdominal Surgery

Postoperative analgesia is an important part of the anesthetic care. According to the recent studies, multimodal analgesia can provide better analgesia \& patient satisfaction with fewer side effect. For example, combining intravenous, intramuscular or oral analgesics with transversus abdominis plane (TAP) block or local anesthetic (LA) infiltration as the multimodal analgesia, can furnish a more effective pain control after the abdominal surgery.

For abdominal surgery, both local infiltration and TAP block target on relieving somatic pain. Local anesthetic wound infiltration is easy to perform with low risk. As the advancement of ultrasound technology, performing the TAP block also becomes easier, safer and more accurate. But whether LA infiltration or TAP block is better for the multimodal analgesia regimen remains unclear.

This study is to compare the postoperative pain score, opioid consumption, side effects, and quality of recovery between these two analgesic methods in patients undergoing abdominal surgery. The investigators hypothesized that TAP block may be more effective than LA infiltration as a part of the multimodal analgesia, and can improve the recovery after the abdominal surgery.

Being tested
transversus abdominis plane block, local infiltration, Patient controlled analgesia
Keywords
transversus abdominis plane block, local infiltration, ropivacaine, heart rate variability, postoperative analgesia
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • transversus abdominis plane blockProcedure or surgery

    bilateral ultrasound-guided transversus abdominis plane block, with 20 ml of 0.25% ropivacaine at each side after the induction of general anesthesia

  • local infiltrationProcedure or surgery

    Also called local anesthetics infiltration

    local anesthetics infiltration at surgical wound with 20 ml of 0.5% ropivacaine before wound closure

  • Patient controlled analgesiaProcedure or surgery

    postoperative analgesia with intravenous patient controlled analgesia with morphine

Study groups in NCT02029755
Study groupRoleWhat they receive
TAP blockExperimentalpostoperative analgesia with sono-guided transversus abdominis plane block and intravenous patient controlled analgesia (IV-PCA). Bilateral sono-guided TAP block will be performed after the induction of general anesthesia. 20 ml of 0.25% ropivacaine will be injected to the transversus abdominis plane under ultrasound guidance at each side (total 40 ml). IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
Receives: Procedure: transversus abdominis plane block; Procedure: Patient controlled analgesia
Local infiltrationActive comparatorpostoperative analgesia with local anesthetics infiltration at surgical wound and intravenous patient controlled analgesia (IV-PCA). 20 ml of 0.5% ropivacaine will be injected at the surgical wound by the surgeon before the closure of wound. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
Receives: Procedure: local infiltration; Procedure: Patient controlled analgesia
PCA onlyActive comparatorpostoperative analgesia with intravenous patient controlled analgesia. IV-PCA with morphine will be ready for postoperative pain control at the end of the surgery.
Receives: Procedure: Patient controlled analgesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Score (NRS: Numerical Rating Scale)

    pain scores of the participants will be followed at postoperative 1, 6, 24, 48 hour (up to 48 hours).

    (NRS: from 0 to 10, 0 = no pain, 10 = the worst pain) The higher score idicates the worse outcome.

    Measured: postoperative 24 hour dynamic

  2. Opioid Consumption

    opioid consumption of the participants will be followed at postoperative 1, 6, 12, 24, 36, 48 hour (up to 48 hours).

    Measured: postoperative 48 hour

Secondary outcomes (11)
  1. Sedation Scale

    Measured: postoperative 1, 6, 24, 48 hour

  2. Nausea and Vomiting Categorical Score

    Measured: postoperative 1, 6, 24, 48 hour

  3. Rescue Analgesic Use

    Measured: postoperative 1, 6, 12, 24, 36, 48 hour

  4. Rescue Antiemetics Use

    Measured: postoperative 1, 6, 12, 24, 36, 48 hour

  5. Time to the First Request of Analgesics

    participants will be followed for the duration of hospital stay

    Measured: an expected average of 5 days

  6. Pruritus

    Measured: postoperative 1, 6, 24, 48 hour

  7. Quality of Recovery 40

    Measured: postoperative 48 hour

  8. Heart Rate Variability

    Measured: preoperative, postoperative 1 hour and 1 day

  9. Time to Flatus

    participants will be followed for the duration of hospital stay

    Measured: an expected average of 5 days

  10. Length of Hospital Stay

    participants will be followed for the duration of hospital stay

    Measured: an expected average of 5 days

  11. Number of Participants With Intervention-related Complication

    participants will be followed for the duration of hospital stay

    Measured: an expected average of 5 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2014 (estimated)
  2. Study startDec 2013
  3. Primary completionApr 2014
  4. Study completionJun 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
108 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02029755
Sponsor's protocol ID
201309028
Acronym
TAP
Status last verified
May 2015
First submitted
5 Jan 2014
Last updated
8 Jun 2015
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing transversus abdominis plane block and local infiltration in people with Postoperative Pain, run by Taipei Medical University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 8 Jun 2015). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Score (NRS: Numerical Rating Scale) (time frame: postoperative 24 hour dynamic). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in